just raised $15m. And now have considerable cash in the bank to pursue the development of the biochip and 12CQ chip. by most metrics I’d say that is positive.
The current price might be lower than recent shareholders entry, but that shouldn’t cast a shadow over the company’s progress. Last raise a bit over a year ago was at 60 cents. Now more than double. Id say that is significant progress.
unfortunately the recent rise brought a new cohort of “investor” chasing the quick buck, where patience seems to be as short as the ascent from $1.50 to $3.00. And the HC discussion in recent months has shifted from the company’s progress to individual’s successes/failures trading the stock.
sometimes just got to cut through discussion here and focus on what really matters. Frankly, a few failed trades don’t mean much in scheme of things.
AXE Price at posting:
$1.51 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)